Your browser doesn't support javascript.
loading
Baseline hepatitis B core antibody predicts treatment response in chronic hepatitis B patients receiving long-term entecavir.
Xu, J-H; Song, L-W; Li, N; Wang, S; Zeng, Z; Si, C-W; Li, J; Mao, Q; Zhang, D-Z; Tang, H; Sheng, J-F; Chen, X-Y; Ning, Q; Shi, G-F; Xie, Q; Yuan, Q; Yu, Y-Y; Xia, N-S.
Afiliação
  • Xu JH; Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China.
  • Song LW; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China.
  • Li N; Xiamen Innovax Biotech Co., Ltd., Xiamen, China.
  • Wang S; Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China.
  • Zeng Z; Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China.
  • Si CW; Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China.
  • Li J; Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China.
  • Mao Q; Department of Infectious Diseases, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Zhang DZ; Department of Infectious Diseases, Southwest China Hospital, Chongqing, China.
  • Tang H; Institute for Viral Hepatitis, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Sheng JF; Department of Infectious Diseases, West China Hospital, Chengdu, China.
  • Chen XY; State Key Laboratory for Diagnosis and Treatment of Infectious Disease, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
  • Ning Q; Department of International Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Shi GF; Department and Institute of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Xie Q; Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
  • Yuan Q; Department of Infectious Diseases, Ruijin Hospital, Jiaotong University School of Medicine, Shanghai, China.
  • Yu YY; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China.
  • Xia NS; Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China.
J Viral Hepat ; 24(2): 148-154, 2017 02.
Article em En | MEDLINE | ID: mdl-27891715
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2017 Tipo de documento: Article